2010 Dec – 2012 Jun | $653k

West Africa Malaria Initiative (WAMI) Spanish Agency for International Development Cooperation (AECID), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Ogobara Doumbo | Africa, Western

Similar Posts

  • TMA-2019 – Clinical Research and Product Development Fellowships

    EDCTP-Clinical Research and Product Development Fellow: Dr Amadou Hamidou Togo, MD, PhD, Université des Sciences Techniques et Technologiques de Bamako(USTTB), Faculty of Pharmacy (FAPH), Malaria Research and Training Center (MRTC) Grant Agreement number: TMA2019IF-2867 Grant Title: TMA2019 IF [ TOGO] Call for proposals: TMA2019 IF [ TOGO] The purpose of this Call for Proposals is to support researchers and members…

  • 2019 Mar – 2024 Feb | $7.09M

    Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women (PYRAPREG) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao | Dem. Rep. Congo, Mozambique, Burkina Faso, Gambia, Mali

  • 2021 Jan – 2023 Dec

    Increasing Intermittent Preventive Treatment uptake through enhanced antenatal clinic service delivery to improve maternal and child health & assessing ANC data for routine monitoring in Mali U.S. President’s Malaria Initiative (PMI), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao, Celia Woodfill | Mali

  • PYRAPREG

    Malaria in pregnant is a public health problem in sub Saharan countries where 11 million pregnancies are exposed to malaria infection. Plasmodium falciparum in pregnant can cause adverse maternal health and poor birth outcomes. Artemisin-based Combination Therapy (ACT) used in treatment of uncomplicated Plasmodium falciparum malaria in pregnant women has the efficacy in Africa. The…

  • 2019 Mar – 2024 Feb | $11.4M

    Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…

Leave a Reply

Your email address will not be published. Required fields are marked *